BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA.
Aline Lopes ChagasAngelo Alves de MattosFlair Jose CarrilhoPaulo Bittencourt de Mirandanull nullDenise Cerqueira Paranaguá VezozzoNatally HorvatManoel de Souza RochaVenancio Avancini Ferreira AlvesGabriela Perdomo CoralMário Reis Alvares-DA-SilvaFábio Marinho Do Rego BarrosMarcos Roberto de MenezesLucas Moretti MonsignoreFabricio Ferreira CoelhoRenato Ferreira da SilvaRita de Cássia Martins Alves da SilvaIlka de Fátima Ferreira Santana BoinLuiz Augusto Carneiro D AlbuquerqueJosé Huygens Parente GarciaGuilherme Eduardo Gonçalves FelgaAirton Mota MoreiraMaria Ignez Freitas Melro BraghiroliPaulo Marcelo Gehm HoffVivianne Barretto de MelloMariana Fonseca DottoriTiago Pugliese BrancoLeonardo de Lucca SchiavonThaisa de Fátima Almeida CostaPublished in: Arquivos de gastroenterologia (2020)
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. The Brazilian Society of Hepatology (SBH) published in 2015 its first recommendations about the management of HCC. Since then, new data have emerged in the literature, prompting the governing board of SBH to sponsor a single-topic meeting in August 2018 in São Paulo. All the invited experts were asked to make a systematic review of the literature reviewing the management of HCC in subjects with cirrhosis. After the meeting, all panelists gathered together for the discussion of the topics and the elaboration of updated recommendations. The text was subsequently submitted for suggestions and approval of all members of the Brazilian Society of Hepatology through its homepage. The present manuscript is the final version of the reviewed manuscript containing the recommendations of SBH.